跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELIGARD leuprorelin acetate 30mg modified release injection syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ELIGARD leuprorelin acetate 30mg modified release injection syringe
Approved
STANDARD
ELIGARD leuprorelin acetate 30mg modified release injection syringe
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
96ad54e1d8f81cc7
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
96ad54e1d8f81cc7
Product Name
ELIGARD leuprorelin acetate 30mg modified release injection syringe
Artg Id
97451
Artg Name
ELIGARD leuprorelin acetate 30mg modified release injection syringe
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2003-11-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7ef7f076e8884cef69ee7566d2753c01.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fea015c2e822e8205f64d3d17e6d174e.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
96ad54e1d8f81cc7
Type
Standard
Back to TGA Approvals
